| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.07B | 20.12B | 18.05B | 17.75B | 19.23B | 20.20B |
| Gross Profit | 6.91B | 6.64B | 5.72B | 5.74B | 6.04B | 5.36B |
| EBITDA | 3.60B | 3.27B | 2.47B | 2.17B | 2.10B | 1.66B |
| Net Income | 2.16B | 1.96B | 2.15B | 1.82B | 1.63B | 1.03B |
Balance Sheet | ||||||
| Total Assets | 26.94B | 27.64B | 28.28B | 23.96B | 23.06B | 26.22B |
| Cash, Cash Equivalents and Short-Term Investments | 1.12B | 1.93B | 2.34B | 2.11B | 3.05B | 2.29B |
| Total Debt | 5.79B | 4.79B | 4.79B | 3.65B | 3.87B | 5.20B |
| Total Liabilities | 12.70B | 13.68B | 13.97B | 11.79B | 12.29B | 15.92B |
| Stockholders Equity | 14.24B | 13.96B | 14.30B | 12.17B | 10.77B | 10.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.74B | -706.00M | -1.02B | 3.20B | 638.00M |
| Operating Cash Flow | 0.00 | 2.15B | -206.00M | -860.00M | 3.35B | 859.00M |
| Investing Cash Flow | 0.00 | -471.00M | -517.00M | 151.00M | -263.00M | -300.00M |
| Financing Cash Flow | 0.00 | -2.08B | 956.00M | -230.00M | -2.33B | -617.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥118.66B | 17.71 | 19.52% | 0.13% | 28.27% | 27.15% | |
75 Outperform | ¥175.15B | 16.57 | ― | 1.53% | 3.37% | 21.35% | |
72 Outperform | ¥139.49B | 3.86 | 8.07% | 2.64% | 79.29% | 35.48% | |
72 Outperform | ¥6.98T | 26.86 | 32.32% | 0.91% | 27.53% | 137.34% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥2.07T | 7.80 | 10.06% | 1.21% | 10.52% | 60.75% | |
59 Neutral | ¥49.52B | 195.39 | ― | 5.01% | -32.74% | -117.06% |